Work

Lack of Efficacy and Safety of Eculizumab for Treatment of Antibody-Mediated Rejection Following Renal Transplantation

Year: 2022

Type: article

Study design: Clinical Trial

Source: Transplantation Proceedings

DOI: 10.1016/j.transproceed.2022.08.008

Authors: Sujung Heo, Youngchan Park, Nagyeom Lee, Yanghyeon Kim, Ye Na Kim, Ho Sik Shin, Yeonsoon Jung, Hark Rim, Helmut G. Rennke, Anil Chandraker

Institutions: Kosin University Gospel Hospital, Kosin University, Brigham and Women's Hospital, Harvard University

Language: English

Topic: Renal Transplantation Outcomes and Treatments

Subfield: Transplantation

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Alexion Pharmaceuticals, Ministry of Education, National Research Foundation of Korea

Award: G315978785

OpenAlex ID: W4298626038

FWCI: 1.573

Cites: 35

Cited by: 8

Related to: 10